Shots: AbbVie collaborated with Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) to develop a novel Ab to prevent and treat COVID-19. The collaboration focuses on advancing 47D11, discovered by UU, EMC and HBM that targets the domain of the spike protein of SARS-CoV-2 AbbVie will support UU, EMC, and HBM in […]Read More
Shots: The companies enter into an agreement to evaluate the combination of Innovent’s Tyvyt with Shenogen’s SNG1005 for the patients with advanced cancer Shenogen has in-licensed SNG1005 and has exclusive rights to develop & commercialize it in Greater China. SNG1005 has completed multiple P-II trials in the US with an approved NMPA’s IND application of […]Read More
Shots: MannKind and One Drop collaborate to integrate MannKind’s BluHale, a Bluetooth connected accessory attached to Afrezza inhaler in to the One drop platform. In H1’19, One drop announced clinical study results assessing Afrezza with One Drop, which demonstrated improvement in A1C levels The focus of the agreement is to provide seamless experience for patients […]Read More
Shots: Verastem to receive $5M up front, $42M as development & commercial milestones and royalties on sales of Copiktra in the licensed territories. Sanofi to get exclusive rights to develop and commercialize Copiktra and hold the marketing authorization & product license in Russia and CIS, Turkey, the Middle East & Africa The focus of the […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
